Patient Square Capital
Latest statistics and disclosures from Patient Square Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ROIV, ARGX, INSM, ONC, COGT, and represent 57.78% of Patient Square Capital's stock portfolio.
- Added to shares of these 10 stocks: BLTE (+$19M), LEGN (+$18M), NKTR (+$15M), COGT (+$11M), MRK (+$9.6M), ARGX (+$7.8M), DBVT (+$7.0M), DFTX (+$6.3M), HROW (+$5.6M), TARA (+$5.4M).
- Started 7 new stock positions in NKTR, TARA, LEGN, MRK, DFTX, BLTE, CTMX.
- Reduced shares in these 10 stocks: INSM (-$18M), TERN (-$13M), LQDA (-$7.8M), SYRE (-$7.5M), MIRM (-$6.3M), OCUL (-$5.9M), IRON (-$5.9M), AVTX (-$5.7M), DNTH, ELVN.
- Sold out of its positions in AMLX, AVTX, IRON, LQDA, OCUL, TERN.
- Patient Square Capital was a net buyer of stock by $30M.
- Patient Square Capital has $564M in assets under management (AUM), dropping by 20.65%.
- Central Index Key (CIK): 0001819257
Tip: Access up to 7 years of quarterly data
Positions held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 29 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 40.1 | $226M | 8.2M | 27.70 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 4.8 | $27M | +41% | 37k | 730.25 |
|
| Insmed Com Par $.01 (INSM) | 4.6 | $26M | -41% | 158k | 163.52 |
|
| Beone Medicines Sponsored Ads (ONC) | 4.2 | $24M | +16% | 81k | 296.97 |
|
| Cogent Biosciences (COGT) | 4.1 | $23M | +87% | 596k | 38.49 |
|
| Mirum Pharmaceuticals (MIRM) | 3.8 | $21M | -22% | 230k | 92.38 |
|
| Belite Bio Sponsored Ads (BLTE) | 3.3 | $19M | NEW | 117k | 159.44 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 3.2 | $18M | NEW | 990k | 18.09 |
|
| Nektar Therapeutics Com New (NKTR) | 2.7 | $15M | NEW | 210k | 71.95 |
|
| Dbv Technologies S A Sponsored Ads (DBVT) | 2.6 | $15M | +93% | 694k | 20.89 |
|
| Pharvaris N V (PHVS) | 2.5 | $14M | -9% | 493k | 28.25 |
|
| Abivax Sa Sponsored Ads (ABVX) | 2.4 | $14M | -6% | 121k | 111.35 |
|
| Xenon Pharmaceuticals (XENE) | 2.3 | $13M | +66% | 227k | 58.15 |
|
| Celcuity (CELC) | 1.9 | $11M | -20% | 95k | 114.14 |
|
| Eyepoint Com New (EYPT) | 1.8 | $10M | 795k | 12.89 |
|
|
| Merck & Co (MRK) | 1.7 | $9.6M | NEW | 80k | 120.29 |
|
| Arcutis Biotherapeutics (ARQT) | 1.7 | $9.4M | +90% | 401k | 23.56 |
|
| Allogene Therapeutics (ALLO) | 1.5 | $8.4M | -30% | 3.5M | 2.44 |
|
| Kymera Therapeutics (KYMR) | 1.5 | $8.3M | -28% | 100k | 83.29 |
|
| Dianthus Therapeutics (DNTH) | 1.4 | $7.9M | -37% | 94k | 83.92 |
|
| Enliven Therapeutics (ELVN) | 1.4 | $7.8M | -35% | 200k | 39.20 |
|
| Perspective Therapeutics Com New (CATX) | 1.2 | $6.8M | +43% | 1.6M | 4.17 |
|
| Definium Therapeutics Com Shs (DFTX) | 1.1 | $6.3M | NEW | 331k | 18.90 |
|
| Harrow Health (HROW) | 1.0 | $5.8M | +2249% | 165k | 35.26 |
|
| Protara Therapeutics Com Stk (TARA) | 1.0 | $5.4M | NEW | 1.0M | 5.21 |
|
| Cytomx Therapeutics (CTMX) | 0.9 | $5.1M | NEW | 1.1M | 4.70 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.7 | $4.2M | +14% | 195k | 21.60 |
|
| Assembly Biosciences Com New (ASMB) | 0.7 | $3.8M | +7% | 136k | 27.75 |
|
| Spyre Therapeutics Com New (SYRE) | 0.0 | $50k | -99% | 1.0k | 50.44 |
|
Past Filings by Patient Square Capital
SEC 13F filings are viewable for Patient Square Capital going back to 2022
- Patient Square Capital 2026 Q1 filed May 15, 2026
- Patient Square Capital 2025 Q4 filed Feb. 12, 2026
- Patient Square Capital 2025 Q3 filed Nov. 10, 2025
- Patient Square Capital 2025 Q2 filed Aug. 11, 2025
- Patient Square Capital 2025 Q1 filed May 14, 2025
- Patient Square Capital 2024 Q4 filed Feb. 14, 2025
- Patient Square Capital 2024 Q3 filed Nov. 14, 2024
- Patient Square Capital 2024 Q1 filed May 14, 2024
- Patient Square Capital 2023 Q4 filed Feb. 13, 2024
- Patient Square Capital 2023 Q3 filed Nov. 14, 2023
- Patient Square Capital 2023 Q2 filed Aug. 11, 2023
- Patient Square Capital 2023 Q1 filed May 10, 2023
- Patient Square Capital 2022 Q4 filed Feb. 13, 2023